ArticleMolecular biology reports2024

ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2).

Nirajan Ghosal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.